Literature DB >> 31478952

XEN Implant Fracture During Needling Procedure.

Sara Olivari1,2, Carlo A Cutolo1,2, Letizia Negri1,2, Francesca Cappelli1,2, Valeria Testa1,2, Michele Iester1,2, Carlo E Traverso1,2.   

Abstract

PURPOSE: The XEN implant is a small hydrophilic stent designed to be implanted permanently for the treatment of glaucoma. As with other bleb-forming surgical procedures, needling is part of postoperative care. We describe 3 cases of XEN fracture of the subconjunctival portion that occurred during the needling procedure.
METHODS: The purpose of this study was to describe the clinical and anatomic outcomes in 3 cases of XEN fracture caused by the needling procedure.
RESULTS: In our case series of XEN procedures (n=170), bleb needling has been performed in 98 cases (57.6%). In 3 cases (3.1%), we observed unintentional damage to the implant after the procedure.The mean distal segment length of the fractured XEN measured 0.83 (range: 0.7 to 1) mm. Despite the adverse event, the mean IOP changed from 25.0 (range: 21 to 30) mm Hg before needling to 12.0 (range: 10 to 14) after needling, with a mean follow-up of 15.3 (range: 11 to 18) months. No vision-threatening complications were recorded during the entire follow-up.
CONCLUSIONS: XEN fracture related to the needling procedure should be considered as a possible adverse event of bleb management. Because XEN is composed of a soft and flexible gelatin material, it could be easily damaged by the needle. The fracture does not seem to impair the efficacy of the draining device. As a matter of fact, according to Poiseuille's laws, shortening of the implant's length decreases the resistance while increasing the flow rate. Despite our positive results, it is recommended to preserve the integrity of the implant.

Entities:  

Year:  2019        PMID: 31478952     DOI: 10.1097/IJG.0000000000001360

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  The Use of Fixation Suture to Treat Inferonasal Hypertrophic Bleb after Xen Gel Stent Implant: A Case Report.

Authors:  Jasna Pavičić-Astaloš; Emmanuel Ankamah; John M Nolan; Eugene Ng; Julian García-Feijoo
Journal:  Case Rep Ophthalmol       Date:  2022-04-04

2.  Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent.

Authors:  Anna Do; Elyse McGlumphy; Aakriti Shukla; Sonal Dangda; Joel S Schuman; Michael V Boland; Jithin Yohannan; Joseph F Panarelli; E Randy Craven
Journal:  Ophthalmol Glaucoma       Date:  2020-12-13

3.  Choroidal Detachment after XEN Gel Stent Implantation.

Authors:  Carlo Alberto Cutolo; Letizia Negri; Sara Olivari; Francesca Cappelli; Carlo Enrico Traverso; Michele Iester
Journal:  J Ophthalmol       Date:  2021-03-06       Impact factor: 1.909

4.  Xen45 gel stent ab interno trimming for ostium occlusion: case report.

Authors:  Filippo Tatti; Pietro Gentile; Lorenzo Mangoni; Giuseppe Demarinis; Pietro Napoli; Maurizio Fossarello
Journal:  BMC Ophthalmol       Date:  2021-12-27       Impact factor: 2.209

5.  Two-year Outcomes of XEN Implantation with Minimal Bleb Needling.

Authors:  Zaria C Ali; Nadeem Moshin; Mohamad T Hakim; Vikas Shankar
Journal:  J Curr Glaucoma Pract       Date:  2022 May-Aug

6.  Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation.

Authors:  Aitor Fernández-García; Ying Zhou; Mercedes García-Alonso; Henry D Andrango; Francisco Poyales; Nuria Garzón
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

7.  Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.

Authors:  Alessandro Rabiolo; Karl Mercieca; Raj Bhayani; Jose Maria Martínez de la Casa; Michele Figus; Karsten Klabe
Journal:  Eye (Lond)       Date:  2022-03-12       Impact factor: 3.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.